Lung cancer screening update

Journal of Carcinogenesis

Volumn 12, Issue , 2013, Pages

  Dhillon, Samjot ^a   Loewen, Gregory ^b   Jayaprakash, Vijayvel ^a   Reid, Mary ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Providence Cancer Center   (United States)

Author keywords

Early detection; lung cancer; screening

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; AUTOFLUORESCENCE IMAGING; BRONCHOSCOPY; BRONCHUS BIOPSY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; HUMAN; LOW DOSE COMPUTED TOMOGRAPHY; LUNG CANCER; LUNG NODULE; MEDICAL SOCIETY; META ANALYSIS (TOPIC); RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING CESSATION; SURVIVAL RATE; THORAX RADIOGRAPHY; WHITE LIGHT;

EID: 84885381323     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.106681     Document Type: Article

References (49)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Centers for Disease Control and Prevention (CDC). Vital signs: Current cigarette smoking among adults aged ≥8 years-United States, 2005-2010. MMWR Morb Mortal Wkly Rep 2011;60:1207-12.
3. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14. (Pubitemid 47357522)
4. Wood DE, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240-65.
5. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guidelines for management of small pulmonary nodules detected on CT scans: A statement from the Fleischner Society. Radiology 2005;237:395-400. (Pubitemid 41507873)
6. Holin SM, Dwork RE, Glaser S, Rikli AE, Stocklen JB. Solitary pulmonary nodules found in a community-wide chest roentgenographic survey; a five-year follow-up study. Am Rev Tuberc 1959;79:427-39.
7. Eddy DM. Screening for lung cancer. Ann Intern Med 1989;111:232-7. (Pubitemid 19190916)
8. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
9. Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al. Screening by chest radiograph and lung cancer mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306:1865-73.
10. Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000;343:1627-33. (Pubitemid 32162988)
11. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 1999;354:99-105. (Pubitemid 29313143)
12. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71. (Pubitemid 44631359)
13. Gopal M, Abdullah SE, Grady JJ, Goodwin JS. Screening for lung cancer with low-dose computed tomography: A systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol 2010;5:1233-9.
14. Reich JM. A critical appraisal of overdiagnosis: Estimates of its magnitude and implications for lung cancer screening. Thorax 2008;63:377-83. (Pubitemid 351497954)
15. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-13.
16. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010;102:1771-9.
17. National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, et al. The National Lung Screening Trial: Overview and study design. Radiology 2011;258:243-53.
18. Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, et al. Lung cancer screening with spiral CT: Baseline results of the randomized DANTE trial. Lung Cancer 2008;59:355-63. (Pubitemid 351335108)
19. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial-Overall design and results of the prevalence round. J Thorac Oncol 2009;4:608-14.
20. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74. (Pubitemid 46175408)
21. Ru Zhao Y, Xie X, de Koning HJ, Mali WP, Vliegenthart R, Oudkerk M. NELSON lung cancer screening study. Cancer Imaging 2011;11:S79-84.
22. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
23. Fontham ET, Wender R. American Cancer Society Interim Guidance on Lung Cancer Screening, 2012. Available from: http://www.cancer.org/acs/groups/ content/@editorial/documents/document/acspc-030879.pdf. [Last accessed: January 29, 2013].
24. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: A systematic review. JAMA 2012;307:2418-29.
25. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-8.
26. Providing Guidance on Lung Cancer Screening To Patients and Physicians, 2012. Available from: http://www.lung.org/lung-disease/lung-cancer/lung-cancer- screening-guidelines/lung-cancer-screening.pdf. [Last accessed: January 29, 2013].
27. McWilliams A, Mayo J, MacDonald S, leRiche JC, Palcic B, Szabo E, et al. Lung cancer screening: A different paradigm. Am J Respir Crit Care Med 2003;168:1167-73. (Pubitemid 37421833)
28. Lam S, MacAulay C, Le Riche JC, Dyachkova Y, Coldman A, Guillaud M, et al. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst 2002;94:1001-9. (Pubitemid 34814729)
29. Merrick DT, Kittelson J, Winterhalder R, Kotantoulas G, Ingeberg S, Keith RL, et al. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: Evaluation of potential targets for chemoprevention of lung cancer. Clin Cancer Res 2006;12:2281-8.
30. Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, et al. Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev Res (Phila) 2011;4:793-802.
31. Loewen G, Natarajan N, Tan D, Nava E, Klippenstein D, Mahoney M, et al. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax 2007;62:335-40. (Pubitemid 46580577)
32. Loewen GM, et al. Detection of premalignant bronchial epithelial abnormalities in high-risk patients. Proc ASCO 2002;21:447.
33. Lam S, Palcic B. Re: Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst 1999;91:561-2.
34. Edell E, Lam S, Pass H, Miller YE, Sutedja T, Kennedy T, et al. Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: An international, multicenter clinical trial. J Thorac Oncol 2009;4:49-54.
35. Massion PP, Carbone DP. The molecular basis of lung cancer: Molecular abnormalities and therapeutic implications. Respir Res 2003;4:12.
36. Gomperts BN, Spira A, Elashoff DE, Dubinett SM. Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection. Cancer Prev Res (Phila) 2010;3:420-3.
37. Perdomo C, Spira A, Schembri F. MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis. Mutat Res 2011;717:32-7.
38. Malerba M, Ragnoli B, Corradi M. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects. Monaldi Arch Chest Dis 2008;69:128-33.
39. Jiang YW, Chen LA. microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review). Mol Med Report 2012;5:890-4.
40. Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 2012;5:992-1006.
41. Silvestri GA. Screening for lung cancer: It works, but does it really work? Ann Intern Med 2011;155:537-9.
42. Silvestri GA, Nietert PJ, Zoller J, Carter C, Bradford D. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax 2007;62:126-30.
43. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001;345:181-8. (Pubitemid 32662128)
44. Silvestri GA, Handy J, Lackland D, Corley E, Reed CE. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998;114:675-80. (Pubitemid 28433723)
45. Wiener RS, Schwartz LM, Woloshin S, Welch HG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: An analysis of discharge records. Ann Intern Med 2011;155:137-44.
46. Gierada DS, Pilgram TK, Ford M, Fagerstrom RM, Church TR, Nath H, et al. Lung cancer: Inter observer agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology 2008;246:265-72. (Pubitemid 350305052)
47. Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: Recommended interim guidelines for assessment and management. Radiology 2009;253:606-22.
48. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004;231:440-5. (Pubitemid 38552902)
49. van der Aalst CM, van Klaveren RJ, van den Bergh KA, Willemsen MC, de Koning HJ. The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J 2011;37:1466-73.